Delivery Order SPE2DB22D2206-SPE2DB24FGS71
Award Date
4/17/24
Potential Completion Date
4/18/24
Potential Value
$4.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, is for the delivery of VYVANSE 30 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The contract, valued at $5,433.46, is a Firm Fixed Price Delivery Order with a completion date of June 28, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of VYVANSE 30 MG CAPSULE 100S, a pharmaceutical product. The contract, valued at $5,556.49, was awarded by the Defense Logistics Agency (DLA), a defense agency, on June 5, 2024 and has a completion date of June 6, 2024. The contract is a delivery order with a firm fixed price pricing type and does not have a set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical...
This federal contract award is for the delivery of VYVANSE 50 MG CAPSULE 100S to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a total ceiling value of $1,337.70 and is a delivery order with a firm fixed price. The contract has an ultimate completion date of April 2, 2025 and was awarded on April 1, 2025. The place of performance is Conshohocken, PA....
This federal contract award is for the delivery of VYVANSE 30 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The $4,203.89 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 4, 2020 with a completion date of November 5, 2020. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is a for-profit organization registered in the System for Award Management (SAM.gov). The contract does...
This federal contract award is for the delivery of VYVANSE 20 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is a firm fixed price delivery order with a potential value of $2,155.00 and a completion date of February 6, 2024. Amerisourcebergen Drug Corp also holds an indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $4,959.42, is for the delivery of 4564630210 - VYVANSE 20 MG CAPSULE 100S, a prescription medication. The contract has a firm fixed price and is set to be completed by May 17, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
This federal contract award is for the delivery of VYVANSE 70 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order valued at $6,070.58 with a firm fixed price and an ultimate completion date of November 8, 2023. The contract was awarded on November 7, 2023, and there was no set-aside used. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that...
This federal contract award is for the delivery of VYVANSE 70 MG CAPSULE 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,481.07 firm fixed-price contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 27, 2024 and is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of VYVANSE 30 MG CAPSULE 100S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense (DoD). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation. The contract has a ceiling value of $4,668.22 and is structured as a Delivery Order with a Firm Fixed Price pricing type. It does not have a...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office division is for the delivery of VYVANSE 70 MG CAPSULE 100S, a pharmaceutical product. The contract, valued at $1,129.08, was awarded by the Defense Logistics Agency (DLA) on July 19, 2024 and has a completion date of July 22, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there is no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded...